Manal Alasnag
Latest contributions
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support
10 Feb 2020
The use of MCS has been increasing over the last 10 years. This study mainly aims at defining the indications for Impella use in the U.S as well as comparing the outcomes, costs, and length of stay in the pre-Impella versus Impella era.
Reviewer
Reviewer
